GSK acquired Zejula as part of its $5.1 billion takeover of Tesaro in 2018, along with other oncology drug candidates, including latecomer PD-1 inhibitor Jemperli (dostarlimab) and others ...

The entrance to the Rolls Building, which houses the Business and Property Courts of England and Wales. A court in the UK has said that GSK should pay AstraZeneca a higher royalty rate on sales of ...

The market value of Zai Lab has not appreciated considerably since my "Hold" sentiment. Check out why I'm transitioning from ...

A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP ...

INR:9884. best betting sites with instant withdrawal CStone Pharmaceuticals and Burning Rock Medical Sign Collaboration ...

INR:7408. rummy train Johnson & Johnson's Zejula has been granted breakthrough drug status by the US FDA and has entered priority review in mainland China HiFiBiO The ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Infinity Sports Al Johnson & Johnson's Zejula has been granted breakthrough drug status by the US FDA and has entered priority review in mainland Chi ...

INR:0859. 2023 satta king 2023 "Medical Speed ​​Reading Club" Fresenius recalled 13 batches of drugs Lianhua Qingwen was approved in Singapore BMS/Bluebi ...

INR:7658. humko game khelna hai Clover Biopharmaceuticals announces positive Phase I results for its S-Trimer COVID-19 vaccine candidate Tonghua dilemma: Wh ...

INR:5843. manipur state lottery result Luye Pharma's high-content Xuezhikang tablets will soon start clinical trials in China Beware of this virus: T ...

INR:0210. crash game aviator These varieties may be included in the national centralized procurement (attached list) Zejula (niraparib) approved in China for f ...